PHARMACOLOGICAL INTERVENTIONS IN ANIMAL MODELS OF INTELLECTUAL DISABILITIES: TRANSLATIONAL IMPLICATIONS
MULTIPLE SCLEROSIS: PARADIGM OF THE DUALITY INFLAMMATION/NEURODEGENERATION. NEW TREATMENTS
CLINICAL MANIFESTATION OF NEUROPATHIC PAIN. EFFICACY OF CURRENT TREATMENTS
CHRONIC POST SURGICAL ( NEUROPATHIC ) PAIN AND PAIN MEMORY
NEW THERAPEUTIC TARGETS FOR NEUROPATHIC PAIN TREATMENT: THE SIGMA-1 RECEPTOR
OVERVIEW OF OREXINS FUNCTIONS
OREXINERGIC/HYPOCRETINERGIC NEUROTRANSMISSION IN SLEEP-WAKE REGULATION
INVOLVEMENT OF HYPOCRETIN/OREXIN RECEPTOR-1 IN CUE-INDUCED REINSTATEMENT OF NICOTINE SEEKING BEHAVIOUR
AGONIST SIGNAL TRAFFICKING AT SEROTONIN 5-HT2A RECEPTOR IN HUMAN BRAIN: IMPLICATIONS FOR SCHIZOPHRENIA AND ANTIPSYCHOTIC TREATMENT
GALPHAQ INTERACTOME AND NEW SIGNALLING PATHWAYS
STRUCTURAL INSIGHTS INTO OPIOID RECEPTOR FUNCTION
GOVERNMENT AGENCIES: MY TRACK TO THE SPANISH AGENCY OF MEDICINES AND MEDICAL DEVICES
A CAREER IN SCIENTIFIC PUBLISHING: AN EDITOR'S PERSPECTIVE
RESEARCH IN THE PRIVATE SECTOR - ‘PROS AND CONS OF RESEARCH IN THE PRIVATE SECTOR’
THE CHALLENGE OF BIOTECH ENTREPRENEURSHIP IN SPAIN
RESEARCH IN PUBLIC RESEARCH ORGANISMS: ‘IS FEASIBLE THE ACADEMIC CAREER?’
MORPHINE EFFECTS ON NON CODING RNAs ACTIVITY
TEN YEARS OF NEW TECHNOLOGIES APPLIED TO TEACHING AND LEARNING
USING VIRTUAL REALITY IN THE PRACTICAL TEACHING OF PHARMACOLOGY IN THE DEGREE OF MEDICINE. STRENGTHS AND WEAKNESSES
DESIGN, IMPLEMENTATION AND FOLLOW-UP OF A LEARNING PROGRAM BASED ON ACTIVE METHODOLOGIES IN THE SUBJECT OF CLINICAL PHARMACOLOGY IN MEDICAL DEGREE
OSTEOARTHRITIS: A MAJOR OR A MINOR PROBLEM?
POTENTIAL ROLE OF ZINC TRANSPORTERS AS THERAPEUTIC TARGETS IN REGULATION OF HYPOXIA-INDUCED PULMONARY HYPERTENSION : O01-01
OLEASTER® IMPROVES ENDOTHELIAL DYSFUNCTION ASSOCIATED TO ATHEROSCLEROSIS BY REDUCING INFLAMMATORY MEDIATORS AND SUPEROXIDE ANION PRODUCTION : O02-01
COMBINATION OF BINGE ETHANOL AND MDMA IN MICE INCREASES THE PHOSPHORYLATION OF HEAT-SHOCK PROTEINS 27 IN THE RIGHT VENTRICLE : O03-01
A RICE BRAN SUPPLEMENTED-DIET RESTORED THE EDHF-CONTRIBUTION TO THE VASCULAR FUNCTION OF RESISTANCE ARTERIES FROM OBESE ZUCKER RATS : O04-01
EFFECT OF CILOSTAZOL ON ENDOTHELIAL PROGENITOR CELL NUMBER OF PATIENTS WITH INTERMITTENT CLAUDICATION : O05-01
EXPRESSION OF ETS-2 AND CELL ADHESION AND ENDOTHELIAL DIFFERENTIATION MOLECULES IN MONONUCLEAR CELLS OF PATIENTS UNDERGOING CARDIAC SURGERY : O06-01
DIABETIC NEPHROPATHY LESIONS IN A PORCINE EXPERIMENTAL MODEL OF DIABETES MELLITUS : O07-01
PHARMACODYNAMIC/PHARMACOKINETIC ASSESSMENT OF BEMIPARIN AFTER MULTIPLE PROPHYLACTIC AND SINGLE THERAPEUTIC DOSES IN YOUNG AND ELDERLY HEALTHY VOLUNTEERS AND IN SUBJECTS WITH VARYING DEGREES OF RENAL IMPAIRMENT : O08-01
PHARMACOLOGICAL BLOCKADE OF ADENOSINE A2A RECEPTORS (A2AR) PREVENTS RADIATION-INDUCED DERMAL INJURY : O09-01
HEALTH BENEFITS PROVIDED BY FRAXIPURE®, A FRAXINUS EXCELSIOR L. SEED EXTRACT. EVALUATION OF ACUTE AND CHRONIC ADMINISTRATION IN HYPERTENSIVE AND OBESE ANIMAL MODELS : O10-02
CRATAEGUS OXYACANTHA AS ANTIOXIDANT AND INTERCELLULAR COMMUNICATION MODULATOR, IN EXPERIMENTAL ALCOHOLIC LIVER CIRRHOSIS : O11-02
CARDIOPROTECTIVE EFFECT OF A ROSEMARY ( ROSMARINUS OFFICINALIS L.) EXTRACT RICH IN CARNOSIC ACID : O12-02
SCREENING OF THE ANTI-AGING ACTIVITY OF COMPOUNDS ISOLATED FROM MICROALGAE SPECIES IN THE C. ELEGANS MODEL : O13-02
PHALARIS CANARIENSIS EFFECT IN THE PREVENTION AND CONTROL OF METABOLIC SYNDROME INDUCED FOR HYPERCALORIC DIET. MODULATING OXIDATIVE STRESS IN RAT : O14-02
EXTRA VIRGIN OLIVE OIL POLYPHENOLS DOWNREGULATE LPS-INFLAMMATORY REPONSE IN MURINE MACROPHAGES SUPPRESSING NFκB AND MAPKS SIGNALING PATHWAYS : O15-02
CHRONIC CITALOPRAM ADMINISTRATION DESENSITIZES PREFRONTAL CORTEX BUT NOT SOMATODENDRITIC A2-ADRENOCEPTORS IN RAT BRAIN : O16-02
DIFFERENT PHARMACOLOGICAL PROPERTIES OF KETANSERIN AND ALTANSERIN ON SEROTONIN 5-HT2A RECEPTORS IN POSTMORTEM HUMAN BRAIN: INTEREST FOR SCHIZOPHRENIA STUDIES : O17-02
EFFECTS OF CHONDROITIN SULFATE AND GLUCOSAMINE IN COMBINATION IN AN ANIMAL MODEL OF OSTEOARTHRITIS AND OSTEOPOROSIS : O18-03
ATP PLAYS A ROLE IN LEUKOCYTE ACCUMULATION INDUCED BY ABC THROUGH ITS P2X7 RECEPTORS : O19-03
EFFECTS OF DEXKETOPROFEN (DEX) AND/OR TRAMADOL (TRM) ON POSTOPERATIVE HYPERALGESIA AND SPINAL CORD (SC) GLIAL-CEL ACTIVATION IN MICE : O20-03
DESIGN AND FORMULATION OF NANOSPHERES FOR SUSTAINED RELEASE OF INDOMETHACINE : O21-03
ANXIO-DEPRESSIVE SYMPTOMS INDUCED BY ARTHRITIS ARE REVERSED BY TOPICAL ANALGESIC-ANTIINFLAMMATORY TREATMENT : O22-03
UNSAPONIFIABLE FRANTION OF EXTRA VIRGIN OLIVE OIL MODULATES T CELL EFFECTOR FUNCTIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE : O23-03
OREXIN RECEPTOR TYPE 2 (OX2R) BLOCKADE DOES NOT MODIFY THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS (HPA) AXIS ACTIVATION INDUCED BY NALOXONE-PRECIPITATED MORPHINE WITHDRAWAL : O24-03
THE ARYLPIPERAZINE DERIVATIVES LP-211 AND MEL-9 ARE INACTIVATING ANTAGONISTS AT HUMAN SEROTONIN 5-HT7 RECEPTORS : O25-03
5-HT7 RECEPTOR INHIBITS VASODEPRESSOR RESPONSES MEDIATED BY THE RELEASE OF CGRP DUE TO NANC STIMULATION IN PITHED RAT : P01-01
ANTIOXIDANT PROTECTION OF GRAPE POMACE ENZYMATIC EXTRACT AND ITS MAJOR POLYPHENOLS UPON NADPH OXIDASE ACTIVATION AND SUPEROXIDE DISMUTASE INHIBITION : P02-01
SARPOGRELATE TREATMENT INDUCES CHANGES IN THE 5-HYDROXYTRYPTAMINE INHIBITORY RECEPTORS INVOLVED IN THE PRESSOR EFFECT ELICITED BY SYMPATHETIC STIMULATION IN PITHED RATS : P03-01
IN RAT EMBRYO CHROMAFFIN CELLS, MITOCHONDRIA PLAY A MORE DOMINANT ROLE IN THE REGULATION OF CA2+ SIGNALING AND EXOCYTOSIS COMPARED WITH THEIR MOTHERS : P04-01
THE ADIPOKINE VISFATIN INDUCES TELOMERE DAMAGE AND CELL SENESCENCE IN HUMAN ENDOTHELIAL CELLS : P05-01
CHARACTERIZATION BY DIFFERENT DRUGS OF HUMAN MESENTERIC ARTERIES CALCIUM OSCILLATIONS INDUCED BY PHENYLEPHRINE : P06-01
EFAVIRENZ INDUCES THE PRODUCTION OF ROS AND THE EXPRESSION OF ICAM-1 AND VCAM-1 IN ARTERIAL ENDOTHELIAL CELLS : P07-01
DECREASED SERUM LEVELS OF TGF-BETA1 IN AGED PATIENTS UNDERGOING CABG : P08-01
INTRACELLULAR NAMPT PROTECTS AGAINST ATHEROSCLEROSIS IN A PPARγ- DEPENDENT MANNER : P09-01
EFFECT OF METYLPREDNILONE ON ANTITROMBIN ACTIVITY IN HUMAN: PRELIMINAR STUDY BASED ON GENETIC EXPRESSION : P10-01
PPARβ/Δ ATTENUATES PALMITATE-INDUCED ENDOPLASMIC RETICULUM STRESS AND PROVOKES AUTOPHAGY IN HUMAN CARDIAC CELLS : P11-01
DIHYDROPYRIMIDINE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS : P12-01
LYCOPENE PREVENTS HYPERTENSION AND CARDIOVASCULAR HYPERTROPHY PRODUCED BY THE INFUSION OF ANGIOTENSIN II : P13-01
ANTIHYPERTENSIVE THERAPY ASSOCIATED WITH A LOWER RISK OF COGNITIVE IMPAIRMENT. A COMMUNITY PHARMACY STUDY : P14-01
DRUGS PRESCRIPTION PATTERN AND OFF-LABEL USES IN PALLIATIVE CARE : P15-01
THE LONG-TERM EFFECTS OF SYSADOA TREATMENT ON PROGRESSION OF STRUCTURAL CHANGES: PARTICIPANTS FROM THE OSTEOARTHRITIS INITIATIVE PROGRESSION COHORT : P16-01
CT-1 PREVENTS GENTAMICIN-INDUCED ACUTE KIDNEY INJURY : P17-01
SHIKONIN AS A POTENTIAL CHEMOPREVENTIVE AGENT IN COLORECTAL CANCER : P18-01
EFFECT OF COUMARIN AND ESCULETIN ON IL-6 AND IL-8 RELEASE : P19-01
IMPORTANT OF THE PRESENCE OF THE CATECHOL GROUP IN THE NEUROPROTECTIVE ACTIVITY OF PHENOLIC DERIVATIVES : P20-01
ORAL ADMINISTRATION OF THE NADPH-OXIDASE INHIBITOR APOCYNIN AND ITS OXIDATIVE METABOLITE DIAPOCYNIN AMELIORATE INFLAMMATION IN MICE : P21-01
CHRONIC ADMINISTRATION OF POMEGRANATE EXTRACT, (PUNICA GRANATUM), CAUSES ANTIHYPERTENSIVE ACTIVITY IN SPONTANEOUSLY HYPERTENSIVE RATS : P22-01
NEUROPROTECTIVE EFFECTS OF HYDROXYTYROSOL IN STREPTOZOTOCIN-DIABETIC RATS : P23-01
OLEUROPEIN SUPRESSES ASSOCIATED-COLITIS COLORECTAL CARCINOGENESIS IN BALB/C MICE : P24-01
MANDARIN ESSENTIAL OIL AS NATURAL ANTIPATHOGENIC AGENT IN FOODBORNE DISEASE : P25-01
BIOAVAILABILITY AND METABOLISM OF NITRODERIVATIVES OF HYDROXYTYROSOL BY HUMAN CELL MODEL SYSTEMS : P26-01
ESTIMATION OF TOTAL PHENOLIC CONTENT IN SIDERITIS HYSSOPIFOLIA : P27-01
EVALUATION OF THE EFFECTIVENESS OF ENROFLOXACIN AGAINST THE MAIN PATHOGENS CAUSING MASTITIS IN SHEEP : P28-01
PHARMACOKINETICS OF ALFAXAN AFTER INTRAVENOUS AND INTRAMUSCULAR ADMINISTRATION TO CATS : P29-01
PHARMACOKINETIC/PHARMACODYNAMIC ASSESSMENT AND MILK PENETRATION FOR A LONG-ACTING DANOFLOXACIN FORMULATIONS IN LACTATING SHEEP : P30-01
PHARMACOKINETICS AND MILK PENETRATION OF A LONG-ACTING POLOXAMER FORMULATIONS FOR ENROFLOXACIN AND ITS METABOLITE CIPROFLOXACIN IN LACTATING SHEEP : P31-01
COMPARATIVE MINIMUM INHIBITORY AND MUTANT PREVENTION CONCENTRATION OF FLUOROQUINOLONES AGAINST STAPHYLOCOCCUS AUREUS STRAINS ISOLATED FROM OVINE AND CAPRINE CLINICAL MASTITIS IN SPAIN : P32-01
ISOLATION, IDENTIFICATION AND TOXICOKINETICS OF AN ANTIMICROBIAL PHOSPHOLIPASE A2 OF THE VENOM BOTHROPS ASPER : P33-01
INTERACTION OF DEXMEDETOMIDINE AND ALFAXAN® IN RABBITS : P34-01
CHARACTERISING THE POST-ANTIFUNGAL EFFECTS OF ECHINOCANDINS AGAINST CANDIDA SPECIES : P35-01
ACTIVATION OF CASPASES AND REACTIVE OXYGEN SPECIES GENERATION BY GARDENIN B IN HUMAN LEUKEMIA CELLS : P36-01
USE OF ANIMATIONS IN PHARMACOLOGY AS MOTIVATIONAL TOOL IN CLASSROOM : P37-01
PHARMACOTHERAPY REVISITED. A SERIES ILLUSTRATING SOME OF THE DIFFICULTIES OF SCIENTIFIC DISSEMINATION : P38-01
THE OPINION OF FORMER STUDENTS ON A COURSE ON DRUG RESEARCH. AN EXPERIENCE OF 10 YEARS AT POMPEU FABRA UNIVERSITY : P39-01
SMALL GROUP-WIKI WORK PLUS PEER-REVIEW ASSESSMENT IMPROVED LEARNING OF ANALGESIC DRUGS : P40-01
DISCOVERY LEARNING IN PHARMACOLOGY PRACTICES IMPROVES STUDENTS' RESULTS : P41-01
CANNABIS AND CANNABINOIDS: THERAPEUTIC USE : P42-01
ASSESSING STUDENTS' KNOWLEDGE AND UNDERSTANDING OF PHARMACOLOGY BY A REEVALUATION WITH DIFFERENT TYPES OF EXAMS : P43-01
CONSTRUCTING NETWORKS OF KNOWLEDGE BETWEEN CHRONIC PATIENTS, STUDENTS, TEACHERS AND PHARMACISTS : P44-01
IMPLEMENTATION OF ROLE-PLAYING TO IMPROVE COMMUNICATION SKILLS AND PROFESSIONAL PRACTICE IN PHARMACEUTICAL CARE : P45-01
PRESS AND INTERNET NEWS AS AN EDUCATIVE TOOL IN PHARMACOGNOSY : P46-01
SECOND-YEAR PHYSICAL THERAPY STUDENTS' ATTITUDES AND PERCEPTIONS ON PHARMACOLOGY : P47-01
MODULATION OF PERIPHERAL μ-OPIOID ANALGESIA BY σ1 RECEPTORS : P48-02
ANALYSIS OF AUTOPHAGIC PROTEIN MARKERS IN COLONIC MUCOSA OF IBD PATIENTS : P49-02
CHONDROITIN SULFATE EFFECTS ON IMMUNOREGULATORY NEUROPEPTIDES LEVELS IN OA PATIENTS WITH SYNOVITIS : P50-02
INDUCTION OF WNT PATHWAY IN EPITHELIAL CELLS BY M2 MACROPHAGES: RELEVANCE IN IBD : P51-02
RATIONAL USE OF DRUGS IN PATIENTS DIAGNOSED OF FIBROMYALGIA : P52-02
CONDITIONED MEDIA FROM ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS EXERTS ANTI-INFLAMMATORY EFFECTS ON OSTEOARTHRITIC CHONDROCYTES : P53-02
STUDY TO ASSESS THE EFFECT OF CS IN PERIODONTAL DISEASE : P54-02
DEFICIENT CYCLOOXYGENASE-2 (COX-2) INDUCTION IN PSORIATIC FIBROBLASTS IS INDEPENDENT OF C/EBP, NF-κB AND MAPKS ACTIVATION : P55-02
EFFECTS OF MESENCHYMAL STEM CELLS IN AN ACUTE INFLAMMATION MODEL IN MOUSE : P56-02
CELL VOLUME REGULATION MODULATES THE NLRP3 INFLAMMASOME VIA TRP-CHANNEL ACTIVATION : P57-02
THE PROGRESSION OF ARTHRITIS IN THE K/BXN SERUM TRANSFER MODEL: CHRONIFICATION VS. RESOLUTION : P58-02
THROMBOSPONDIN-1: A NOVEL CHONDROITIN SULFATE TARGET FOR OSTEOARTHRITIS TREATMENT : P59-02
EFFECTS OF CHONDROITIN SULFATE ON THE GENE EXPRESSION PROFILE IN IL-1β STIMULATED SYNOVIAL FIBROBLAST CELLS CULTURES : P60-02
THE EFFECTS OF CHONDROITIN SULFATE ON INFLAMMASOME ACTIVATION : P61-02
CHONDROITIN SULFATE REGULATES TWO ANTI-ANGIOGENIC FACTORS IN HUMAN OSTEOARTHRITIC SYNOVIAL FIBROBLASTS : P62-02
DRUGS AND RARE DISEASES: COULD THEY BE DEVELOPED AT UNIVERSITIES? : P63-02
UNRAVELLING THE STRUCTURAL DETERMINANTS FOR OBTAINING NEW PDE7 ALLOSTERIC MODULATORS : P64-02
TRANSLOCATION OF BETA-ARRESTIN II BY FRACTALKINE AT CX3CR1 RECEPTORS: IMPACT OF RECEPTOR NON-SYNONYMOUS SINGLE NUCLEOTIDE POLYMORPHISMS (NSSNPS) : P65-02
MORPHINE ADMINISTRATION MODULATES EXPRESSION OF DOPAMINE-RELATED TRANSCRIPTION FACTORS INVOLVED IN MIDBRAIN DOPAMINERGIC NEURONS FUNCTION : P66-02
THE EFFECT OF THE ANTIRETROVIRAL DRUG EFAVIRENZ ON HUMAN HEPATIC CELLS LACKING FUNCTIONAL MITOCHONDRIA (RHO∘ PHENOTYPE) : P67-02
ROLE OF CRF1-RECEPTOR IN THE ENHANCEMENT OF TYROSINE-HYDROXYLASE PHOSPHORILATION AT SERINE 40 (THPSER40) AFTER MORPHINE WITHDRAWAL IN THE RIGHT VENTRICLE : P68-02
CIGLITAZONE INHIBITS ENDOTHELIAL TO MESENCHIMAL TRANSITION IN HUMAN PRIMARY ENDOTHELIAL CELLS : P69-02
STRUCTURAL AND ELECTROPHYSIOLOGICAL CHARACTERIZATION OF SPONTANEOUSLY CONTRACTILE SKELETAL MUSCLE ENGINEERED FROM DERMAL PRECURSOR CELLS : P70-02
CHARACTERIZATION OF A SEROTONIN 5-HT2A RECEPTOR MUTATED AT THE CHOLESTEROL CONSENSUS MOTIF : P71-02
IDENTIFICATION OF ACTIVE COMPOUNDS ON SEROTONIN 2A RECEPTOR (5-HT2A) BY HIGH THOUGHPUT SCREENING : P72-02
ANTIDEPRESSANT EFFECTS OF NANOENCAPSULATED OXOISOAPORPHINES : P73-02
DIFFERENTIAL TIME COURSE OF TRANSCRIPTION FACTORS MRNA EXPRESSION IN ORGANOTYPIC HIPPOCAMPAL AND CORTICAL SLICE CULTURES AFTER TREATMENT WITH RS67333, A PUTATIVE FASTER-ACTING ANTIDEPRESSANT DRUG : P74-02
HIGHER QUANTAL SIZE AND SLOWER KINETICS OF SINGLE EXOCYTOTIC EVENTS IN CHROMAFFIN CELLS FROM THE SOD1G93A MOUSE MODEL OF AMYOTROPHIC LATERAL SCLEROSIS : P75-02
INVOLVEMENT OF NITRIC OXIDE-DEPENDENT SIGNALLING PATHWAYS IN μ-OPIOID RECEPTOR DESENSITIZATION OF RAT LOCUS COERULEUS NEURONS : P76-02
PROPOFOL INDUCE HIGHER AMNESIC EFFECT THAN SEVOFLURANE AND ISOFLURANE ANAESTHESIA IN THE RAT : P77-02
RESIDENCE TIME OF THE NOVEL ANTIPSYCHOTIC LURASIDONE AT SEROTONIN 5-HT7 RECEPTORS : P78-02
NEUROPROTECTIVE EFFECT OF IGF-II ON ADULT RAT CORTEX NEURONS IN CULTURE : P79-02
MODULATION OF FUNCTIONAL TURNOVER OF μ-OPIOID RECEPTORS IN RAT LOCUS COERULEUS NEURONS BY CHRONIC TREATMENTS WITH OPIOID AGONISTS : P80-02
THE SELECTIVE 5-HT4-RECEPTOR PARTIAL AGONIST RS-67,333 EXHIBITS FASTER ANTIDEPRESSANT EFFECTS THAN FLUOXETINE IN OLFACTORY BULBECTOMIZED MICE : P81-02
THE NEUROPROTECTION EXERTED BY MEMANTINE, MINOCYCLINE AND LITHIUM AGAINST NEUROTOXICITY OF CEREBROSPINAL FLUIDS (CSF) FROM PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS) IS ANTAGONIZED BY RILUZOLE : P82-02
NEUROPSYCHOPHARMACOLOGY BMP AND ACTIVIN MEMBRANE BOUND INHIBITOR (BAMBI) CONSTITUTES A NEW THERAPEUTIC TARGET FOR THE TREATMENT OF ANXIETY DISORDERS THROUGH A MECHANISM INVOLVING MIRNA-488 : P83-02
THE CANNABINOID RECEPTOR 1 ASSOCIATES WITH NMDA RECEPTORS TO PRODUCE GLUTAMATERGIC HYPOFUNCTION: IMPLICATIONS FOR PSYCHOSIS AND SCHIZOPHRENIA : P84-02
ALTERED BDNF EXPRESSION AND CB1-RECEPTOR FUNCTIONALITY IN THE BRAIN OF GFAP KNOCKOUT MICE EXHIBITING AN ANXIOGENIC-LIKE BEHAVIOR : P85-02
INFLUENCE OF DIFFERENT LEVELS OF REELIN IN THE FUNCTIONALITY OF 5HT2A RECEPTORS IN SYNAPTOSOMES : P86-02
MATERNAL ETHANOL BINGE DRINKING PRODUCES ALTERATIONS IN EMOTION AND DRUG CONSUMPTION BEHAVIOR IN ADOLESCENT OFFSPRING MICE : P87-02
FRUCTOSE SUPPLEMENTATION EXACERBATES GLUCOSE INTOLERANCE AND CAUSES ADIPOSE TISSUE INFLAMMATION IN PPARβ/Δ-DEFICIENT MICE : P88-02
THE PPARβ/Δ AGONIST GW501516 INHIBITS ENDOPLASMIC RETICULUM STRESS-INDUCED INFLAMMATION AND INSULIN RESISTANCE IN SKELETAL MUSCLE CELLS : P89-02
OVEREXPRESSION OF PROLACTIN COULD IMPROVE LIPOLYSIS OF ADIPOCYTES AND PANCREATIC INSULIN RELEASE IN THE IRS2-/- MICE : P90-02
EFFECT OF CYTOCHROME P450 2D6 ON RISPERIDONE PHARMACOKINETICS AND EXTRAPYRAMIDAL SYMPTOMS IN HEALTHY VOLUNTEERS: RESULTS FROM A PHARMACOGENETIC CLINICAL TRIAL : P91-02